Filter by Category:
Feb 14, 2024
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
Feb 01, 2024
Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative
Oct 02, 2023